Literature DB >> 11796171

Renaturation and purification of bone morphogenetic protein-2 produced as inclusion bodies in high-cell-density cultures of recombinant Escherichia coli.

Luis Felipe Vallejo1, Maren Brokelmann, Sabine Marten, Susanne Trappe, Joaquin Cabrera-Crespo, Andrea Hoffmann, Gerhard Gross, Herbert A Weich, Ursula Rinas.   

Abstract

Eschericha coli was genetically engineered to produce recombinant human bone morphogenetic protein-2 (rhBMP-2) in a non-active aggregated form using a temperature-inducible expression system. High concentrations of both biomass (75 g cell dry weight per liter of culture broth) and inactive rhBMP-2 (8.6 gl(-1)) were obtained by applying a high-cell-density cultivation procedure. After washing and solubilizing the inclusion bodies, rhBMP-2 was refolded and dimerized at concentrations up to 100 mgl(-1) by means of a simple dilution method with yields exceeding 50%. Finally, a one-step purification procedure based on affinity chromatography was implemented to isolate the rhBMP-2 dimer. With the established renaturation and purification protocols, yields of more than 10 mg rhBMP-2 dimer per gram cell dry weight were obtained corresponding to 750 mg rhBMP-2 dimer per liter of culture broth. The purified rhBMP-2 dimer showed biological activity equivalent to CHO produced rhBMP-2 as tested by the induction of alkaline phosphatase activity in C2C12 cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11796171     DOI: 10.1016/s0168-1656(01)00425-4

Source DB:  PubMed          Journal:  J Biotechnol        ISSN: 0168-1656            Impact factor:   3.307


  31 in total

1.  Production of hepatopoietin Cn in high-cell-density cultures of recombinant Escherichia coli and detection of its antioxygen activity.

Authors:  Yang Liu; Xiao-Li Li; Dong-Dong Zhang; Qiang Wang; Yong Liu; Dong-Mei Liu; Chu-Tse Wu; Chun-Ping Cui
Journal:  Mol Biotechnol       Date:  2011-02       Impact factor: 2.695

2.  High efficient expression of bioactive human BMP-14 in E. coli using SUMO fusion partner.

Authors:  Jian Feng Li; Xian Wei Cui; Hai Yan Ji; Ting Qiu; Xue Mei Ji; Ming Xian Du; Hai Tao Wu; Xing Zhou Xu; Shuang Quan Zhang
Journal:  Protein J       Date:  2011-12       Impact factor: 2.371

3.  Stability and Biological Activity of E. coli Derived Soluble and Precipitated Bone Morphogenetic Protein-2.

Authors:  Bastian Quaas; Laura Burmeister; Zhaopeng Li; Alexandra Satalov; Peter Behrens; Andrea Hoffmann; Ursula Rinas
Journal:  Pharm Res       Date:  2019-11-20       Impact factor: 4.200

Review 4.  Increasing recombinant protein production in Escherichia coli through metabolic and genetic engineering.

Authors:  Hendrik Waegeman; Wim Soetaert
Journal:  J Ind Microbiol Biotechnol       Date:  2011-09-08       Impact factor: 3.346

5.  Phosphonic acid monolayers for binding of bioactive molecules to titanium surfaces.

Authors:  Nina Adden; Lara J Gamble; David G Castner; Andrea Hoffmann; Gerhard Gross; Henning Menzel
Journal:  Langmuir       Date:  2006-09-12       Impact factor: 3.882

Review 6.  Production of recombinant proteins in E. coli by the heat inducible expression system based on the phage lambda pL and/or pR promoters.

Authors:  Norma A Valdez-Cruz; Luis Caspeta; Néstor O Pérez; Octavio T Ramírez; Mauricio A Trujillo-Roldán
Journal:  Microb Cell Fact       Date:  2010-03-19       Impact factor: 5.328

7.  Isolation of cell-free bacterial inclusion bodies.

Authors:  Escarlata Rodríguez-Carmona; Olivia Cano-Garrido; Joaquin Seras-Franzoso; Antonio Villaverde; Elena García-Fruitós
Journal:  Microb Cell Fact       Date:  2010-09-17       Impact factor: 5.328

8.  A dose- and time-controllable syngeneic animal model of breast cancer microcalcification.

Authors:  Fangbing Liu; Preeti Misra; Elaine P Lunsford; Joanne T Vannah; Yuxia Liu; Robert E Lenkinski; John V Frangioni
Journal:  Breast Cancer Res Treat       Date:  2009-09-17       Impact factor: 4.872

9.  Optimized procedure for expression and renaturation of recombinant human bone morphogenetic protein-2 at high protein concentrations.

Authors:  Hongbin Zhang; Jie Wu; Yu Zhang; Na Fu; Jie Wang; Shujin Zhao
Journal:  Mol Biol Rep       Date:  2009-10-13       Impact factor: 2.316

10.  Effects of porous beta-tricalcium phosphate-based ceramics used as an E. coli-derived rhBMP-2 carrier for bone regeneration.

Authors:  Jae Hyup Lee; Mi Young Ryu; Hae-Ri Baek; Kyung Mee Lee; Jun-Hyuk Seo; Hyun-Kyung Lee; Hyun-Seung Ryu
Journal:  J Mater Sci Mater Med       Date:  2013-06-01       Impact factor: 3.896

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.